
1. front cell infect microbiol. 2012 oct 26;2:131. doi: 10.3389/fcimb.2012.00131.
ecollection 2012.

novel approaches develop rift valley fever vaccines.

indran sv(1), ikegami t.

author information: 
(1)department pathology, university texas medical branch galveston, tx,
usa.

rift valley fever (rvf) endemic sub-saharan africa, spread into
madagascar, egypt, saudi arabia, yemen. rift valley fever virus (rvfv) the
family bunyaviridae, genus phlebovirus causes hemorrhagic fever, neurological
disorders blindness humans, high rate abortion fetal malformation
in ruminants. rvfv classified category priority pathogen overlap
select agent cdc/usda due potential impact public health and
agriculture. gap safety immunogenicity traditional rvf
vaccines; formalin-inactivated rvfv vaccine tsi-gsd-200 requires three doses 
for protection, live-attenuated smithburn vaccine risk cause
abortion fetal malformation pregnant ruminants. review, problems
of traditional vaccines safety efficacy recently reported novel
rvf candidate vaccines including subunit vaccines, virus vector, replicons
are discussed.

doi: 10.3389/fcimb.2012.00131 
pmcid: pmc3481114
pmid: 23112960  [indexed medline]

